인쇄하기
취소

New warning for Champix

Published: 2008-02-14 06:58:00
Updated: 2008-02-14 06:58:00
The Korea Food and Drug Administration said it has called for increased awareness of the health risks of the smoking cessation drug Champix (varenicline).

To that end, the administration has requested Pfizer Korea, the manufacturer of Champix, to revise the summary of product characteristics in its insert paper.

The agency said it appears increasingly likely that there may be an associati...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.